NDC 73377-094-01 - Losartan Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-094
- Requested NDC
- 73377-094-01
- Package NDCs from labels
- 73377-094-01, 73377-094-02, 73377-094-03, 73377-094-04, 73377-094-05, 73377-094-06, 73377-094-07
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-05-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-05-19 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-094-01 | Losartan Potassium | 100 g in 1 JAR | POWDER | 100 | 7 | |
| 73377-094-02 | Losartan Potassium | 25 g in 1 JAR | POWDER | 25 | 7 | |
| 73377-094-03 | Losartan Potassium | 1000 g in 1 JAR | POWDER | 1000 | 7 | |
| 73377-094-04 | Losartan Potassium | 97 g in 1 JAR | POWDER | 97 | 7 | |
| 73377-094-05 | Losartan Potassium | 80 g in 1 JAR | POWDER | 80 | 7 | |
| 73377-094-06 | Losartan Potassium | 500 g in 1 JAR | POWDER | 500 | 7 | |
| 73377-094-07 | Losartan Potassium | 1500 g in 1 JAR | POWDER | 1500 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | 3585b1d3-ccb7-747e-e063-6294a90a4b77 | 2025-05-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | 3585fdcc-d22a-b0a6-e063-6294a90a9b0c | 2025-05-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals.Inc. | 351d3c5c-05c6-921a-e063-6394a90abef9 | 2025-05-14 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | 27e783ce-3353-448a-b0a3-c954dfd2e4c7 | 2025-04-15 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | e0f63126-6890-48bf-9c25-444dc5974ecd | 2025-02-05 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | adc984d5-91d6-ef17-e053-2a95a90a7571 | 2025-02-04 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan potassium | LOSARTAN POTASSIUM | Coupler LLC | 2d5524d5-c76b-44af-e063-6294a90a2ef1 | 2025-02-04 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 5e35e3b9-7d79-b32a-e053-2991aa0ae9c0 | 2025-02-03 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan potassium | LOSARTAN POTASSIUM | Coupler LLC | 2d1b1648-8b24-cf4f-e063-6294a90afdd8 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan potassium Tablets, 100 mg | LOSARTAN POTASSIUM | Coupler LLC | 2d1b03bb-2355-baac-e063-6294a90a9b40 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8b36fa56-4274-4fc6-bdba-ca7a399b2b21 | 2025-01-24 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d8284747-07b6-9775-e053-2a95a90ad52d | 2025-01-21 | Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d88ad738-a915-7679-e053-2a95a90a58c7 | 2025-01-21 | Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | cf4278a3-fbb7-a8ab-e053-2a95a90abc0f | 2025-01-20 | Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | d1ed9593-a587-55bb-e053-2995a90a8a9a | 2025-01-20 | Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | d1ee193e-bf78-3134-e053-2a95a90a65d2 | 2025-01-20 | Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | d2021060-94d7-3e1d-e053-2995a90a10ee | 2025-01-20 | Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | DirectRx | d358499d-5ebb-75b2-e053-2a95a90a4223 | 2025-01-20 | Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Direct_Rx | e9aa536e-0747-45bf-e053-2995a90ae7d6 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | DIRECT RX | a5b5da65-a4d5-1bd5-e053-2a95a90a6a60 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.